His current area of research interest is the study of monoclonal gammopathies, especially multiple myeloma, from a clinical, epidemiological and genomic point of view. He participates in the European IMMEnSE (International Multiple Myeloma Research) Consortium and in several Spanish PETHEMA clinical trials.